Cargando…
Interruptions in Supplies of Second-Line Antituberculosis Drugs — United States, 2005–2012
Autores principales: | Seaworth, Barbara J., Field, Kim, Flood, Jennifer, Saliba, Jouhayna, Mase, Sundari R., Cronin, Ann, Shah, Neha, Jereb, John, Chorba, Terence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
U.S. Centers for Disease Control
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604838/ https://www.ncbi.nlm.nih.gov/pubmed/23325352 |
Ejemplares similares
-
Impact of a Shortage of First-Line Antituberculosis Medication on Tuberculosis Control — United States, 2012–2013
por: Warkentin, Jon, et al.
Publicado: (2013) -
National Shortage of Purified-Protein Derivative Tuberculin Products
por: Jereb, John, et al.
Publicado: (2013) -
Reply to Chang and Yew
por: Sotgiu, Giovanni, et al.
Publicado: (2020) -
Keeping It in the Family: the Childhood Burden of Tuberculosis
por: Chorba, Terence, et al.
Publicado: (2017) -
Confusion in the Genesis of Art and Disease: Charles Laval, Paul Gauguin, and Tuberculosis
por: Chorba, Terence, et al.
Publicado: (2020)